Epigenetic resetting in the human germ line entails histone modification remodeling
Science Advances · 20.01.2023 · 9 (3)
DOI: 10.1126/sciadv.ade1257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 20.01.2023. Verfasst von Wolfram H Gruhn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome Trust/Cancer Research UK Gurdon Institute, Henry Wellcome Building of Cancer and Developmental Biology, Cambridge CB2 1QN, UK. Hauptthemen laut MEDLINE: Histone Code, DNA Methylation. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Biotechnology and Biological Sciences Research Council, Medical Research Council.
Abstract (Originalsprache)
Epigenetic resetting in the mammalian germ line entails acute DNA demethylation, which lays the foundation for gametogenesis, totipotency, and embryonic development. We characterize the epigenome of hypomethylated human primordial germ cells (hPGCs) to reveal mechanisms preventing the widespread derepression of genes and transposable elements (TEs). Along with the loss of DNA methylation, we show that hPGCs exhibit a profound reduction of repressive histone modifications resulting in diminished heterochromatic signatures at most genes and TEs and the acquisition of a neutral or paused epigenetic state without transcriptional activation. Efficient maintenance of a heterochromatic state is limited to a subset of genomic loci, such as evolutionarily young TEs and some developmental genes, which require H3K9me3 and H3K27me3, respectively, for efficient transcriptional repression. Accordingly, transcriptional repression in hPGCs presents an exemplary balanced system relying on local maintenance of heterochromatic features and a lack of inductive cues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wellcome Trust/Cancer Research UK Gurdon Institute, Henry Wellcome Building of Cancer and Developmental Biology, Cambridge CB2 1QN, UK.
- Physiology, Development and Neuroscience Department, University of Cambridge, Cambridge CB2 3EL, UK.
- Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.
- Institute for Informatics, Washington University School of Medicine, St. Louis, MO, USA.
- NORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, J9:30, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, Visionsgatan 4, 17164, Solna, Stockholm, S…
- Centre for Trophoblast Research, University of Cambridge, Cambridge, UK.
ORCID-Profile: Wolfram H Gruhn, Walfred W C Tang, Sabine Dietmann, João P Alves-Lopes, Christopher A Penfold, Frederick C K Wong, Navin B Ramakrishna, M Azim Surani
Förderung
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Medical Research Council
Zitieren
APA
Gruhn, W. H., Tang, W. W. C., Dietmann, S., Alves-Lopes, J. P., Penfold, C. A., Wong, F. C. K., Ramakrishna, N. B., & Surani, M. A. (2023). Epigenetic resetting in the human germ line entails histone modification remodeling. Science Advances, 9(3). https://doi.org/10.1126/sciadv.ade1257
Vancouver
Gruhn WH, Tang WWC, Dietmann S, Alves-Lopes JP, Penfold CA, Wong FCK, et al. Epigenetic resetting in the human germ line entails histone modification remodeling. Science Advances. 2023;9(3). doi:10.1126/sciadv.ade1257
BibTeX
@article{Gruhn2023,
author = {Gruhn, Wolfram H and Tang, Walfred W C and Dietmann, Sabine and Alves-Lopes, João P and Penfold, Christopher A and Wong, Frederick C K and Ramakrishna, Navin B and Surani, M Azim},
title = {Epigenetic resetting in the human germ line entails histone modification remodeling},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {3},
doi = {10.1126/sciadv.ade1257}
}
EUVIMED